Steady trading for British American Tobacco stock as South Africa plant closure after illicit trade losses

Traders Union
All News
Financial News
British American Tobacco gains 0.11% today

Highlights

British American Tobacco is cutting around 9,000 jobs globally and outsourcing operations, targeting annual cost savings of £600 million by 2028.
The company is consolidating technology roles in India and closing a South African plant after heavy losses from illicit trade.
Shares trade in a mixed pattern near GBX4,722, with momentum signals diverging and an expected range of GBX4,616 to GBX4,827 in the coming days.

Restructuring and outsourcing drive cost focus amid market repositioning

British American Tobacco has launched a comprehensive global restructuring program that will impact around 9,000 roles through direct job cuts and outsourcing, aiming to secure approximately a3600 million in annual cost savings by 2028, according to Thekenyatimes. This move reflects the company's intent to streamline operations and strengthen its long-term profit base, with stability retained in its largest market, the United States, as noted by Hcamag. In parallel, British American Tobacco has transferred select technology functions to ITC Infotech and established a Future Capabilities Centre in India, while also closing its manufacturing facility in South Africa following significant losses attributed to illicit trade, as reported by Businessday Co.

Mixed technical momentum as short-term signals conflict with support levels

From a technical perspective, BATS/GBX is trading below the MA-20 but remains above the MA-50 and MA-200, highlighting a mixed short- and medium-term picture with longer-term support present. Immediate support sits at the Ichimoku Kijun level of GBX4,718. Momentum signals are divergent: the Moving Average Convergence Divergence (MACD) indicates a strong buy, but the Average Directional Index (ADX) remains weak and the Commodity Channel Index (CCI) is neutral. The Relative Strength Index (RSI) is at 53.13, suggesting a mild buying bias, while the Stochastic RSI and CCI are both neutral and Bull/Bear Power is overbought. This combination of indicator and oscillator readings points toward modest intraday buying interest, though caution is warranted given the conflicting momentum cues.

Range-bound outlook seen as volatility and upward bias persist

Over the coming several trading days, BATS is expected to consolidate within a price band of GBX4,616 to GBX4,827, in line with typical recent volatility. With an estimated 75% probability of an upward move, the baseline scenario anticipates ongoing price stabilization inside this range. A break above resistance could trigger further gains and extend the rally, while a fall through immediate support would expose the lower end of the projected band.

Anton Kharitonov, analyst at Traders Union, sees the restructuring program as a key event with tangible cost-saving targets, but remains cautious given mixed technical momentum. He notes that while longer-term support is holding, short-term signals are yet to confirm a sustained trend. Price is consolidating, and conflicting indicators call for patience near current levels. "Until BATS breaks above GBX4,827 or loses GBX4,718, I stay defensive and wait for clearer direction."

Earlier, analysts noted that companies undertaking significant restructuring and efficiency initiatives were increasingly favored by investors for their potential to boost long-term profitability. The current technical consolidation in British American Tobacco, combined with ongoing strategic changes, suggests that higher-than-usual volatility could emerge if the price decisively breaks above or below the established GBX4,616–GBX4,827 range.

Source of Data: BATS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.